Stanford researcher shares encouraging news about COVID vaccines for children under 5

Pfizer asked federal regulators to authorize the COVID-19 vaccine for children under 5 on Tuesday. KTVU's Jana Katsuyama spoke with a Stanford researcher who is leading a study that suggests they've seen no major side effects of the vaccine on this age group since trials started last spring. These children are given one-tenth of the adult dose.